SCHEMBL28290800

SCHEMBL28290800

CCOC(=O)c1ccc(NC(c2ccccc2)C2CCCCC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY2R P49146 1/20 0.54
SMN1; SMN2 Q16637 6/20 0.53
RAB9A P51151 6/20 0.53
NPC1 O15118 5/20 0.53
GAA P10253 2/20 0.53
CASR P41180 1/20 0.53
MAPT P10636 2/20 0.52
TSHR P16473 1/20 0.50
ALDH1A1 P00352 5/20 0.49
HTT P42858 2/20 0.49
POLB P06746 2/20 0.49
KDM4E B2RXH2 1/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
ALOX15 P16050 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28290816 0.88 ALDH1A1 (0.52) SMN1; SMN2NPC1GAATSHRALDH1A1
SCHEMBL28289349 0.87 KMT2A (0.49) SMN1; SMN2RAB9ANPC1GAAMAPT
SCHEMBL5114854 0.82 HTR1E (0.69) NPY2RSMN1; SMN2RAB9ANPC1GAA
SCHEMBL15943121 0.78 MAPT (0.49) NPY2RSMN1; SMN2RAB9ANPC1GAA
SCHEMBL11256349 0.77 SMN1; SMN2 (0.59) NPY2RSMN1; SMN2RAB9ANPC1GAA
SCHEMBL30537465 0.76 CA1 (0.58) SMN1; SMN2GAAMAPTKDM4EMEN1
SCHEMBL771186 0.76 MAPT (0.66) SMN1; SMN2RAB9ANPC1MAPTTSHR
SCHEMBL28290801 0.74 RAB9A (0.53) SMN1; SMN2RAB9ANPC1GAAMAPT
SCHEMBL28891987 0.74 TSHR (0.64) SMN1; SMN2RAB9AGAAMAPTTSHR
SCHEMBL9911362 0.74 RAB9A (0.60) SMN1; SMN2RAB9ANPC1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110003104-A Salicyclic acid derivatives, its pharmaceutically acceptable salt, its composition and its application method 多伦多大学管理委员会 2019-07-12 CN disclosed
CN-105120854-B Novel salicylic acid derivatives, pharmaceutically acceptable salts thereof, compositions thereof, and methods of use thereof 多伦多大学管理委员会 2019-04-09 CN disclosed